CClinicalTrials.gg
Status unknownNCT01735292TimerUpdated Nov 28, 2012

Safety of the Automatic Respiration Transfer System- Timer

An interventional study of Automatic Respiration Transfer System- Timer in Intensive Care Patients on a Ventilator, sponsored by Hadassah Medical Organization. Status unknown at 1 site in Israel. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2012-11-28.

Sponsored by Hadassah Medical Organization · Not applicable and Interventional

The sponsor has not verified this record recently (last verified Nov 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
13 Years and older
Sex
All
01

Study summary

The Israel Terminally Ill Law, 2005 allows patients who are terminally ill and ventilated to have their ventilator placed on a timer which at a specific time in the future stops the ventilator, maintains the patient on positive pressure (CPAP) and allows the patient not to be reconnected to the ventilator. We will evaluate the safety of the Automatic Respiration Transfer-Timer by assessing vital signs, oxygenation and ventilatory pressures and volumes during the use of the timer with the regular ventilator. In addition, we will evaluate whether the timer stops the ventilator and switches to CPAP at the designated time.

02

Conditions studied

  • Intensive Care Patients on a Ventilator

Keywords

  • Ventilation, timer
03

In context

Lead sponsor

Hadassah Medical Organization is the lead sponsor of 659 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Ventilated patients with informed consent

Exclusion criteria

Exclusion Criteria:

  • Non- ventilated patients
05

Study design

Phase
Not applicable
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Interventions

  • DeviceAutomatic Respiration Transfer System- Timer
06

What researchers measure

Primary outcomes

  1. Safety of the Automatic Respiration Transfer System- Timer

    Number of Adverse Events

    Time frame: one year

07

Study locations

1 site
  • Hadassah Medical Organization
    Jerusalem, 93588, Israel
    • Charles Sprung, MD · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01735292
Lead sponsor
Hadassah Medical Organization
Collaborators
Shaare Zedek Medical Center
Responsible party
SPRUNG CHARLES (Director, General Intensive Care Unit, Hadassah Medical Organization) — Principal investigator
First posted
Nov 28, 2012
Start date
Jan 2013
Primary completion
Jan 2014 (estimated)
Completion
Jan 2014 (estimated)
Last update
Nov 28, 2012

Study contacts

Charles Sprung, MD
Contact
charless@ekmd.huji.ac.il
97226778060
Charles Sprung, MD
principal investigator · Hadassah Medical Organization

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion